Adesh University (AU) is private university in Bathinda, Punjab, India. The university was established in 2012 under Adesh University Act, 2012 (Punjab Act 6 of 2012). The campus is spread out on 100-acre land..
Introduction: Nanotechnology has revolutionized various sectors, particularly in biomedical sciences and drug delivery. Among metal oxide nanoparticles, Zinc Oxide Nanoparticles (ZnO NPs) have emerged as a multifunctional agent due to their well-documented antibacterial, anticancer, anti-inflammatory, and antioxidant activities. However, the conventional synthesis of ZnO NPs often involves hazardous reagents, high energy input, and the generation of toxic byproducts, posing risks to both human health and the environment. These challenges necessitate the development of eco-friendly alternatives, such as green synthesis methods employing biological sources. Methods: This review analyzes recent studies on the green synthesis of ZnO NPs using biological sources such as plant extracts, bacteria, and fungi. The pharmacological activities of these biogenically synthesized ZnO NPs were evaluated through in vitro and in vivo experiments, focusing on antibacterial, anticancer, and antioxidant effects. Mechanisms of action were also explored. Results: Green synthesis methods effectively produced ZnO NPs with improved biocompatibility and therapeutic efficacy. Biological entities influenced nanoparticle size, shape, and stability. Antibacterial activity was attributed to membrane disruption and the induction of oxidative stress. Anticancer effects were observed via ROS generation and mitochondrial dysfunction, leading to apoptosis. Antioxidant properties were linked to free radical scavenging capabilities. Discussion: The review highlights the potential of green synthesis as a sustainable and eco-friendly approach to producing pharmacologically active ZnO NPs. Biological agents not only simplify synthesis but also enhance the therapeutic potential of the nanoparticles. Conclusion: Green-synthesized ZnO NPs offer promising biomedical applications due to their enhanced biocompatibility and multifunctional activity. Despite their potential, challenges such as synthesis variability, toxicity concerns, and scalability must be addressed through further toxicological evaluations and clinical studies.
Platelet transfusions are essential for managing thrombocytopenia and bleeding disorders, with single donor platelets (SDP) and random donor platelets (RDP) being the primary products available. While SDPs are often preferred for their reduced donor exposure and theoretically superior outcomes, evidence comparing their post-transfusion increments remains inconclusive. This study aims to compare post-transfusion platelet count increments between patients receiving SDPs versus RDPs. This study included 256 platelet transfusions (97 SDP, 159 RDP). Post-transfusion platelet counts were measured at 6 and 24 h. Absolute count increment (ACI), corrected count increment (CCI), and percentage platelet recovery (PPR) were calculated. Statistical analysis included paired and unpaired t -tests for comparing outcomes between and within groups, with secondary analysis of increment efficacy across different clinical diagnoses. The mean pre-transfusion platelet counts were 39,226 ± 28,412/μL for SDP and 37,849 ± 27,921/μL for RDP ( P = 0.708). ACI at 24 h was significantly higher in the SDP group (44,286 ± 23,982/μL) compared to the RDP group (23,491 ± 17,623/μL; P < 0.001). However, when adjusted for body surface area and number of platelets transfused, CCI showed no significant difference between SDP (17,180 ± 7,918) and RDP (16,095 ± 7,356; P = 0.285). PPR was also comparable between SDP (46.54 ± 19.82%) and RDP (42.49 ± 20.13%; P = 0.117). Clinical conditions including chronic liver disease, extensive burns, and severe infections were associated with poor increments regardless of product type. While SDPs provide significantly higher ACIs, the efficiency as measured by CCI and PPR is comparable between SDPs and RDPs when appropriately dosed. This finding challenges the preference for SDPs based solely on increment considerations. The choice should be guided by patient-specific factors, resource availability, and cost considerations rather than expected increments alone.
The Ziehl–Neelsen (ZN) staining technique, first developed in the late 19 th century, remains a cornerstone in microbiological identification of acid–fast bacilli (AFB). This review explores the historical development, principle, and procedure of the ZN staining method and also highlights its role in diagnosing tuberculosis (TB) and related infections. In addition to standard (hot) ZN staining, numerous modifications have been introduced to accommodate diverse clinical specimens and organisms. The review also discusses alternative techniques such as auramine fluorochrome staining and their comparative advantages. A significant recent advancement is the integration of artificial intelligence (AI) into AFB detection workflows, offering improved accuracy, reduced workload, and faster diagnostics through automated image analysis. Studies demonstrate high sensitivity and specificity of AI-based tools in identifying AFB in ZN-stained slides, suggesting strong potential for implementation in resource-limited settings. As global health efforts intensify against TB and related diseases, the ZN staining method, accompanied by digital innovation, continues to evolve as a pivotal diagnostic tool.